Spots Global Cancer Trial Database for ribonucleotide reductase inhibitor
Every month we try and update this database with for ribonucleotide reductase inhibitor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of the RNR Inhibitor BBI-825 in Subjects With Tumors With Resistance Gene Amplifications | NCT06299761 | Solid Tumor | BBI-825 | 18 Years - 99 Years | Boundless Bio |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
